{
    "clinical_study": {
        "@rank": "60280", 
        "acronym": "TraNsgripe", 
        "arm_group": [
            {
                "arm_group_label": "Influenza vaccine, second administration after 5 weeks", 
                "arm_group_type": "Experimental", 
                "description": "Drug: Influenza vaccine (split virion, inactivated) suspension for injection 0.5ml at the baseline and 5 weeks after the first one."
            }, 
            {
                "arm_group_label": "Influenza vaccine", 
                "arm_group_type": "Active Comparator", 
                "description": "Drug: Influenza vaccine (split virion, inactivated) suspension for injection 0.5ml  at the baseline."
            }
        ], 
        "brief_summary": {
            "textblock": "Randomized, multicenter, open label trial to compare safety and efficacy  of two doses\n      stationary flu vaccination vs one doses in Solid Organ Transplant Recipients."
        }, 
        "brief_title": "Clinical Trial Evaluating Efficacy and Safety of One Dose Versus Two Doses of Influenza Vaccination", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Infection in Solid Organ Transplant Recipients", 
        "condition_browse": {
            "mesh_term": "Influenza, Human"
        }, 
        "detailed_description": {
            "textblock": "The purposes of this study are:\n\n        1. Evaluate the efficacy and safety of a double dose of seasonal flu vaccine compared to a\n           single dose.\n\n        2. Determine the specific cellular immune response produced after the first and second\n           vaccine doses of seasonal flu vaccine by in vitro stimulation  of specific memory cells\n           (A and B flu viruses).\n\n        3. Evaluate the humoral immune response produced after one dose vs two doses of seasonal\n           flu vaccine by the measure of serum antibody levels.\n\n        4. Evaluate clinical efficacy of stationary flu vaccine in solid organ transplant\n           recipients.\n\n        5. Evaluate a long term cellular and humoral response(1 year) of seasonal flu vaccine.\n\n        6. Characterize the genetic expression profile of immune response after the flu vaccine in\n           solid organ transplant recipients by means of a genetic sub-study.\n\n        7. Characterize the flu vaccine effect (one dose and two doses) through the antibody\n           anti-HLA(human leukocyte antigen), and its influence on the rejection rate in solid\n           organ transplant recipients, by means of immunologic sub-study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Solid organ transplant recipient.\n\n          2. 16 years or older.\n\n          3. More than 30 days after transplantation.\n\n          4. Negative pregnancy test for women of childbearing potential\n\n          5. The patient must give informed consent\n\n        Exclusion Criteria:\n\n          1. No written informed consent.\n\n          2. Acute rejection within 15 days prior to vaccination.\n\n          3. Pregnancy.\n\n          4. Hypersensitivity to the active substance, any of the excipients and waste, for\n             example: eggs, egg albumin, chicken proteins.\n\n          5. History of a previous serious reaction to immunization (eg Guillain-Barr\u00e9 syndrome)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "499", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01761435", 
            "org_study_id": "TraNsgripe1-2"
        }, 
        "intervention": {
            "arm_group_label": [
                "Influenza vaccine, second administration after 5 weeks", 
                "Influenza vaccine"
            ], 
            "description": "Patients will be randomized at 1:1 rate and open label fashion, according to centers, and time elapsed since transplant and type of organ transplanted to one of this two interventions :\nA arm (usual treatment):  Influenza vaccine (split virion, inactivated) suspension for injection 0.5ml at the baseline.\nB arm (experimental branch): Influenza vaccine (split virion, inactivated) suspension for injection 0.5ml at the baseline and 5 weeks after the first dose.\nThe follow-up of both arms will be at 5, 10 and 15 weeks and one year after the baseline.", 
            "intervention_name": "Influenza vaccine", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Influenza", 
            "Solid Organ Transplant Recipients"
        ], 
        "lastchanged_date": "November 4, 2013", 
        "link": {
            "description": "The Spanish Network for the Research in Infectious Diseases (REIPI) is based in research groups of high standards and professional level. REIPI\u00b4s aim is to generate scientific knowledge in the field of the infectious diseases, in areas ranging from basic", 
            "url": "http://www.reipi.org/"
        }, 
        "location": [
            {
                "contact": {
                    "email": "mirfac@humv.es", 
                    "last_name": "Carmen Fari\u00f1as \u00c1lvarez, MD", 
                    "phone": "+34 942203263"
                }, 
                "facility": {
                    "address": {
                        "city": "Santander", 
                        "country": "Spain", 
                        "state": "Bilbao"
                    }, 
                    "name": "Hospital Universitario Masqu\u00e9s de Valdecilla"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jcarratala@bellvitgehospital.cat", 
                    "last_name": "Jordi Carratal\u00e1 Fern\u00e1ndez, MD", 
                    "phone": "+ 34 932 607 625"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitario de Bellvitge"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "AMORENO@clinic.ub.es", 
                    "last_name": "Asunci\u00f3n Moreno Camacho, MD", 
                    "phone": "637723240"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Clinic Provincial de Barcelona"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "josemiguelmontejo@hotmail.com", 
                    "last_name": "Miguel Montejo Baranda, MD", 
                    "phone": "686913317"
                }, 
                "facility": {
                    "address": {
                        "city": "Bilbao", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitario de Cruces"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "julian.torre.sspa@juntadeandalucia.es", 
                    "last_name": "Julii\u00e1n de la Torre Cisneros, DM", 
                    "phone": "677 904 280"
                }, 
                "contact_backup": {
                    "email": "laracharo@gmail.com", 
                    "last_name": "Rosario Lara Contreras, DM", 
                    "phone": "670 781 024"
                }, 
                "facility": {
                    "address": {
                        "city": "C\u00f3rdoba", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitario Reina Sof\u00eda"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "flmedrano@yahoo.es", 
                    "last_name": "Francisco L\u00f3pez Medrano, DM", 
                    "phone": "649 944 975"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitario 12 Octubre"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Patricia Mu\u00f1oz Garc\u00eda, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital General Gregorio Mara\u00f1on"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "fortunabete@gmail.com", 
                    "last_name": "Jes\u00fas Fort\u00fan Abete", 
                    "phone": "662435553"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Ram\u00f3n y Cajal"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Joan Gavald\u00e0 Santapau, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Vall d'Hebron"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mariae.cordero.sspa@juntadeandalucia.es", 
                    "last_name": "Mar\u00eda Elisa Cordero, MD", 
                    "phone": "34 955 013414"
                }, 
                "contact_backup": {
                    "email": "claram.rosso.sspa@juntadeandalucia.es", 
                    "last_name": "Clara Mar\u00eda Rosso, MD", 
                    "phone": "34 955 013414"
                }, 
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain", 
                        "zip": "41013"
                    }, 
                    "name": "Hospital Universitario Virgen del Roc\u00edo"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "suarezbenjumea@gmail.com", 
                    "last_name": "Alejandro Su\u00e1rez Benjumea", 
                    "phone": "+34 954533558"
                }, 
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Regional Virgen de la Macarena"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mblanes@ono.com", 
                    "last_name": "Mario Blanes Julia, MD", 
                    "phone": "+34 963 726517"
                }, 
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital la Fe de Valencia"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized, Comparative and Prospective Clinical Trial Evaluating Efficacy and Safety of a Dose of Seasonal Flu Vaccine Compared to Two Doses of Vaccine for Prevention of Influenza in Solid Organ Transplant Recipients", 
        "overall_contact": {
            "email": "mariae.cordero.sspa@juntadeandalucia.es", 
            "last_name": "Maria Elisa Cordero Matia, PhD", 
            "phone": "+34 955 013414"
        }, 
        "overall_contact_backup": {
            "email": "claram.rosso.sspa@juntadeandalucia.es", 
            "last_name": "Clara Mar\u00eda Rosso, MD", 
            "phone": "+34 955013414"
        }, 
        "overall_official": [
            {
                "affiliation": "COMPLEJO HOSPITALARIO REGIONAL REINA SOF\u00cdA", 
                "last_name": "Julian De la Torre Cisneros, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Universitario 12 de Octubre", 
                "last_name": "Francisco L\u00f3pez Medrano, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "HOSPITAL GENERAL GREGORIO MARA\u00d1\u00d3N", 
                "last_name": "Patricia Mu\u00f1oz Garc\u00eda, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Ram\u00f3n y Cajal", 
                "last_name": "Jes\u00fas Fortun Abete, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "HOSPITALS VALL D'HEBRON", 
                "last_name": "Jo\u00e1n Gavald\u00e0 Santapau, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Universitari de Bellvitge", 
                "last_name": "Jordi Carratal\u00e1 Fern\u00e1ndez, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "HOSPITAL CLINIC I PROVINCIAL DE BARCELONA", 
                "last_name": "Asunci\u00f3n Moreno Camacho, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "HOSPITAL UNIVERSITARIO DE CRUCES", 
                "last_name": "Jos\u00e9 Miguel Montejo Baranda, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "HOSPITAL UNIVERSITARI I POLIT\u00c8CNIC LA FE", 
                "last_name": "Marino Blanes Julia, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "COMPLEJO HOSPITALARIO REGIONAL VIRGEN MACARENA", 
                "last_name": "Alejandro Suarez Benjumea, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Universitario Marqu\u00e9s de Valdecilla", 
                "last_name": "Carmen Fari\u00f1as \u00c1lvarez, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO", 
                "last_name": "Maria Elisa Cordero Matia, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Difference in seroconversion rates in both treatment groups at 5, 10, 15 weeks, and 12 months after the first vaccine dose (percent of patients with 4 x increase  in  the pre-vaccination titers).", 
            "measure": "Seroconversion rates", 
            "safety_issue": "No", 
            "time_frame": "At 5, 10, 15 weeks, and 12 months after the first vaccine dose"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01761435"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Geometric average postvaccination antibody titers and rate of increase between pre-and post-vaccination geometric mean, post-vaccination seroprotection rate (or percentage of individuals with a titer 1 / 40 as measured by RIH).", 
                "measure": "Postvaccination antibody titers", 
                "safety_issue": "No", 
                "time_frame": "At 5, 10, 15 weeks, and 12 months after the first vaccine dose."
            }, 
            {
                "description": "Occurrence of grade 3 or 4 toxicity, death, hospitalization, retransplantation, acute rejection and chronic rejection", 
                "measure": "Safety.", 
                "safety_issue": "Yes", 
                "time_frame": "At 5, 10, 15 weeks, and 12 months after the first vaccine dose"
            }, 
            {
                "description": "Detection of clinical cases of influenza following immunization. Nasal swabs to confirm infection with influenza virus by RT-PCR (Reverse transcription polymerase chain reaction).", 
                "measure": "Efficacy", 
                "safety_issue": "No", 
                "time_frame": "At 5, 10, 15 weeks, and 12 months after the first vaccine dose"
            }, 
            {
                "description": "Characterize the flu vaccine effect (one dose and two doses) through the antibody anti-HLA levels, ant its influence on the rejection rate in solid organ transplant recipients, by means of immunologic sub-study.", 
                "measure": "Antibody anti-HLA", 
                "safety_issue": "No", 
                "time_frame": "At 5, 10, 15 weeks, and 12 months after the first vaccine dose"
            }, 
            {
                "description": "Determination of the T cells specific immune response measured by production of INFg, IL-2 and IL-4 in the cytoplasm of CD4+ and CD8 + (mononuclear cells) specific for influenza virus by direct immunofluorescence and flow cytometry analysis.", 
                "measure": "Cellular response", 
                "safety_issue": "No", 
                "time_frame": "At 5, 10, 15 weeks, and 12 months after the first vaccine dose"
            }, 
            {
                "description": "Clinical severity (hospitalization, ICU admission, death, rejection). Time to clinical stability will be register.", 
                "measure": "Clinical complications", 
                "safety_issue": "Yes", 
                "time_frame": "At 5, 10, 15 weeks, and 12 months after the first vaccine dose"
            }
        ], 
        "source": "Fundaci\u00f3n P\u00fablica Andaluza Progreso y Salud", 
        "sponsors": {
            "collaborator": {
                "agency": "Spanish Network for Research in Infectious Diseases", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Fundaci\u00f3n P\u00fablica Andaluza Progreso y Salud", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}